Ashok Kumar Manepalli
Pain Medicine · Concord, NCNPI 1922532381
Payments from drug & device makers
Across 71 payments — averaging $107.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$2K
- Nevro Corp.$1K
- Relievant Medsystems, Inc.$903
- Abbott$197
- SPR Therapeutics, Inc$86
- plus $109 from 3 others
What the payments were for
- Speaking & faculty fees$1,18616%
- Travel & lodging$2,96339%
- Food & beverage$3,46846%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 32 | $2,727 |
| Boston Scientific | 21 | $2,238 |
| Nevro Corp. | 4 | $1,357 |
| Relievant Medsystems, Inc. | 5 | $903 |
| Abbott | 3 | $197 |
| SPR Therapeutics, Inc | 2 | $86 |
| Curonix LLC | 1 | $50 |
| Masimo Corporation | 2 | $40 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,485
- Omnia$1,186
- KYPHON EXPRESS II KYPHOPAK TRAY$883
- SYNCHROMEDII$621
- WaveWriter Alpha Prime 16$435
- GENERAL PAIN MANAGEMENT$306
- INTELLIS ADAPTIVESTIM$260
- INCEPTIV$164
- ETERNA$148
- Senza$111
How this compares
$7,617 in reported general payments places this provider in the 65th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 114 | $2,791 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 114 | $2,762 |
| Gabapentin | 87 | $1,217 |
| Naloxone Hcl | 14 | $882 |
| Pregabalin | 46 | $670 |
| Oxycodone Hcl | 52 | $669 |
| Cyclobenzaprine Hcl | 51 | $477 |
| Morphine Sulfate ErMorphine Sulfate | 17 | $365 |
| Methadone Hcl | 19 | $296 |
| Tramadol Hcl | 37 | $294 |
| Duloxetine Hcl | 12 | $230 |
| Celecoxib | 22 | $201 |
| Methocarbamol | 18 | $148 |
| Tizanidine Hcl | 24 | $118 |
| Baclofen | 11 | $80 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Concord
- Leonardo KapuralWinston Salem$4.1M
- James NorthWinston Salem$3.7M
- Richard RauckWinston Salem$1.7M
- Christopher GilmoreWinston Salem$1.3M
- Binit ShahHuntersville$863K
- Jeffrey PeacockWinston Salem$553K
- Courtney AumanJacksonville$210K
- Javid BakshAsheville$202K
- David ZubLeland$168K
- Jacob WangCharlotte$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.